(UYG) ProShares Ultra Financials - Overview
Etf: Leveraged, Financial, S&P 500, ETF
Dividends
| Dividend Yield | 11.34% |
| Yield on Cost 5y | 10.61% |
| Yield CAGR 5y | 34.78% |
| Payout Consistency | 73.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.6% |
| Relative Tail Risk | 2.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -20.92 |
| Character TTM | |
|---|---|
| Beta | 1.671 |
| Beta Downside | 1.832 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.35% |
| CAGR/Max DD | 0.81 |
Description: UYG ProShares Ultra Financials January 21, 2026
ProShares Ultra Financials (NYSE ARCA: UYG) is a leveraged-equity ETF that seeks to deliver twice the daily performance of an index tracking S&P 500 financial-sector stocks. The fund typically allocates at least 80 % of its assets to futures, swaps, or other derivatives that replicate the index’s exposure, and it is classified as “non-diversified,” meaning concentration risk is higher than in broad-market ETFs.
Key sector drivers that can amplify UYG’s returns include: (1) net interest margin trends in U.S. banks, which have widened by roughly 30 bps year-to-date as the Federal Reserve’s policy rate sits near 5.25 %; (2) insurance underwriting profitability, with combined ratios for major insurers averaging 92 % in Q4 2023, indicating earnings resilience; and (3) the pace of credit growth, where total loan balances grew 5 % YoY in Q3 2024, supporting fee-based revenue streams. These metrics are useful gauges of the underlying financial-sector health that UYG leverages.
For a deeper, data-driven assessment of how UYG’s leverage interacts with these drivers, you might explore ValueRay’s analytics platform for sector-specific risk-adjusted performance tools.
What is the price of UYG shares?
Over the past week, the price has changed by +2.79%, over one month by -8.30%, over three months by +5.79% and over the past year by +0.84%.
Is UYG a buy, sell or hold?
What are the forecasts/targets for the UYG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 105.7 | 18.6% |
UYG Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 754.8m USD (754.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 754.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 754.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 12.07% (E(754.8m)/V(754.8m) * Re(12.07%) + (debt-free company))
Discount Rate = 12.07% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)